Updated Jul 16, 2026
Zummo Jacqueline is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $125K.
Jacqueline Zummo is identified in SEC filings as the Chief Scientific Operations Officer at Protara Therapeutics, Inc. (ticker: TARA). In this capacity, she oversees scientific operations to support the company's oncology and rare-disease programs, including the development of TARA-002 and related therapies.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-09 | TARA | Protara Therapeutics, Inc. | S — Open-market sale [10b5-1] | 1.1K | $5.40 | $6K |
| 2026-04-02 | TARA | Protara Therapeutics, Inc. | S — Open-market sale [10b5-1] | 22.6K | $5.26 | $119K |
| 2026-01-27 | TARA | Protara Therapeutics, Inc. | F — Tax withholding / forfeiture | 3.7K | $6.67 | $25K |
| 2026-01-22 | TARA | Protara Therapeutics, Inc. | F — Tax withholding / forfeiture | 6.6K | $5.60 | $37K |
| 2026-01-21 | TARA | Protara Therapeutics, Inc. | A — Grant or award | 30.0K | $0.00 |
Jacqueline Zummo is identified in SEC filings as the Chief Scientific Operations Officer at Protara Therapeutics, Inc. (ticker: TARA). In this capacity, she oversees scientific operations to support the company's oncology and rare-disease programs, including the development of TARA-002 and related therapies.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($125K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Zummo Jacqueline profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.